Collection of Blood From Patients With Cancer for Analysis of Genetic Differences in Drug Disposition


Condition: Prostate Cancer, Breast Cancer, Lung Cancer, Ovarian Cancer, Lymphoma

Study Type: Observational

Clinical Trials Identifier NCT 8-digits: NCT01441089

Sponsor: National Cancer Institute (NCI)

Phase:

Eligibility:

  • Age: minimum 18 Years maximum N/A
  • Gender: All

Inclusion Criteria:

  1. Cancer patients currently enrolled in a Medical Oncology Branch IRB approved therapeutic trials at the National Cancer Institute are eligible. Ability of patient or Legally Authorized Representative (LAR) to understand and be willing to sign the informed consent document. Must be greater than or equal to

Exclusion Criteria:

  1. Not applicable

View trial on ClinicalTrials.gov